This report contains market size and forecasts of Etoricoxib Intermediate in global, including the following market information:
Global Etoricoxib Intermediate Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Etoricoxib Intermediate Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Etoricoxib Intermediate companies in 2020 (%)
The global Etoricoxib Intermediate market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Etoricoxib Intermediate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Etoricoxib Intermediate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Etoricoxib Intermediate Market Segment Percentages, By Type, 2020 (%)
0.98
0.99
Global Etoricoxib Intermediate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Etoricoxib Intermediate Market Segment Percentages, By Application, 2020 (%)
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Chronic Low Back Pain
Acute Pain
Others
Global Etoricoxib Intermediate Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Etoricoxib Intermediate Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Etoricoxib Intermediate revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Etoricoxib Intermediate revenues share in global market, 2020 (%)
Key companies Etoricoxib Intermediate sales in global market, 2016-2021 (Estimated), (MT)
Key companies Etoricoxib Intermediate sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Novacap
Abbott
Pfizer
Geri-Care
Perrigo
Kopran
Merck
Sun Pharmaceutical
GlaxoSmithKline
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Etoricoxib Intermediate Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Etoricoxib Intermediate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Etoricoxib Intermediate Overall Market Size
2.1 Global Etoricoxib Intermediate Market Size: 2021 VS 2027
2.2 Global Etoricoxib Intermediate Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Etoricoxib Intermediate Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Etoricoxib Intermediate Players in Global Market
3.2 Top Global Etoricoxib Intermediate Companies Ranked by Revenue
3.3 Global Etoricoxib Intermediate Revenue by Companies
3.4 Global Etoricoxib Intermediate Sales by Companies
3.5 Global Etoricoxib Intermediate Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Etoricoxib Intermediate Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Etoricoxib Intermediate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Etoricoxib Intermediate Players in Global Market
3.8.1 List of Global Tier 1 Etoricoxib Intermediate Companies
3.8.2 List of Global Tier 2 and Tier 3 Etoricoxib Intermediate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Etoricoxib Intermediate Market Size Markets, 2021 & 2027
4.1.2 0.98
4.1.3 0.99
4.2 By Type - Global Etoricoxib Intermediate Revenue & Forecasts
4.2.1 By Type - Global Etoricoxib Intermediate Revenue, 2016-2021
4.2.2 By Type - Global Etoricoxib Intermediate Revenue, 2022-2027
4.2.3 By Type - Global Etoricoxib Intermediate Revenue Market Share, 2016-2027
4.3 By Type - Global Etoricoxib Intermediate Sales & Forecasts
4.3.1 By Type - Global Etoricoxib Intermediate Sales, 2016-2021
4.3.2 By Type - Global Etoricoxib Intermediate Sales, 2022-2027
4.3.3 By Type - Global Etoricoxib Intermediate Sales Market Share, 2016-2027
4.4 By Type - Global Etoricoxib Intermediate Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Etoricoxib Intermediate Market Size, 2021 & 2027
5.1.2 Rheumatoid Arthritis
5.1.3 Psoriatic Arthritis
5.1.4 Osteoarthritis
5.1.5 Ankylosing Spondylitis
5.1.6 Chronic Low Back Pain
5.1.7 Acute Pain
5.1.8 Others
5.2 By Application - Global Etoricoxib Intermediate Revenue & Forecasts
5.2.1 By Application - Global Etoricoxib Intermediate Revenue, 2016-2021
5.2.2 By Application - Global Etoricoxib Intermediate Revenue, 2022-2027
5.2.3 By Application - Global Etoricoxib Intermediate Revenue Market Share, 2016-2027
5.3 By Application - Global Etoricoxib Intermediate Sales & Forecasts
5.3.1 By Application - Global Etoricoxib Intermediate Sales, 2016-2021
5.3.2 By Application - Global Etoricoxib Intermediate Sales, 2022-2027
5.3.3 By Application - Global Etoricoxib Intermediate Sales Market Share, 2016-2027
5.4 By Application - Global Etoricoxib Intermediate Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Etoricoxib Intermediate Market Size, 2021 & 2027
6.2 By Region - Global Etoricoxib Intermediate Revenue & Forecasts
6.2.1 By Region - Global Etoricoxib Intermediate Revenue, 2016-2021
6.2.2 By Region - Global Etoricoxib Intermediate Revenue, 2022-2027
6.2.3 By Region - Global Etoricoxib Intermediate Revenue Market Share, 2016-2027
6.3 By Region - Global Etoricoxib Intermediate Sales & Forecasts
6.3.1 By Region - Global Etoricoxib Intermediate Sales, 2016-2021
6.3.2 By Region - Global Etoricoxib Intermediate Sales, 2022-2027
6.3.3 By Region - Global Etoricoxib Intermediate Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Etoricoxib Intermediate Revenue, 2016-2027
6.4.2 By Country - North America Etoricoxib Intermediate Sales, 2016-2027
6.4.3 US Etoricoxib Intermediate Market Size, 2016-2027
6.4.4 Canada Etoricoxib Intermediate Market Size, 2016-2027
6.4.5 Mexico Etoricoxib Intermediate Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Etoricoxib Intermediate Revenue, 2016-2027
6.5.2 By Country - Europe Etoricoxib Intermediate Sales, 2016-2027
6.5.3 Germany Etoricoxib Intermediate Market Size, 2016-2027
6.5.4 France Etoricoxib Intermediate Market Size, 2016-2027
6.5.5 U.K. Etoricoxib Intermediate Market Size, 2016-2027
6.5.6 Italy Etoricoxib Intermediate Market Size, 2016-2027
6.5.7 Russia Etoricoxib Intermediate Market Size, 2016-2027
6.5.8 Nordic Countries Etoricoxib Intermediate Market Size, 2016-2027
6.5.9 Benelux Etoricoxib Intermediate Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Etoricoxib Intermediate Revenue, 2016-2027
6.6.2 By Region - Asia Etoricoxib Intermediate Sales, 2016-2027
6.6.3 China Etoricoxib Intermediate Market Size, 2016-2027
6.6.4 Japan Etoricoxib Intermediate Market Size, 2016-2027
6.6.5 South Korea Etoricoxib Intermediate Market Size, 2016-2027
6.6.6 Southeast Asia Etoricoxib Intermediate Market Size, 2016-2027
6.6.7 India Etoricoxib Intermediate Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Etoricoxib Intermediate Revenue, 2016-2027
6.7.2 By Country - South America Etoricoxib Intermediate Sales, 2016-2027
6.7.3 Brazil Etoricoxib Intermediate Market Size, 2016-2027
6.7.4 Argentina Etoricoxib Intermediate Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Etoricoxib Intermediate Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Etoricoxib Intermediate Sales, 2016-2027
6.8.3 Turkey Etoricoxib Intermediate Market Size, 2016-2027
6.8.4 Israel Etoricoxib Intermediate Market Size, 2016-2027
6.8.5 Saudi Arabia Etoricoxib Intermediate Market Size, 2016-2027
6.8.6 UAE Etoricoxib Intermediate Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Etoricoxib Intermediate Major Product Offerings
7.1.4 Bayer Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.1.5 Bayer Key News
7.2 Novacap
7.2.1 Novacap Corporate Summary
7.2.2 Novacap Business Overview
7.2.3 Novacap Etoricoxib Intermediate Major Product Offerings
7.2.4 Novacap Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.2.5 Novacap Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Etoricoxib Intermediate Major Product Offerings
7.3.4 Abbott Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.3.5 Abbott Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Etoricoxib Intermediate Major Product Offerings
7.4.4 Pfizer Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Geri-Care
7.5.1 Geri-Care Corporate Summary
7.5.2 Geri-Care Business Overview
7.5.3 Geri-Care Etoricoxib Intermediate Major Product Offerings
7.5.4 Geri-Care Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.5.5 Geri-Care Key News
7.6 Perrigo
7.6.1 Perrigo Corporate Summary
7.6.2 Perrigo Business Overview
7.6.3 Perrigo Etoricoxib Intermediate Major Product Offerings
7.6.4 Perrigo Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.6.5 Perrigo Key News
7.7 Kopran
7.7.1 Kopran Corporate Summary
7.7.2 Kopran Business Overview
7.7.3 Kopran Etoricoxib Intermediate Major Product Offerings
7.4.4 Kopran Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.7.5 Kopran Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Etoricoxib Intermediate Major Product Offerings
7.8.4 Merck Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.8.5 Merck Key News
7.9 Sun Pharmaceutical
7.9.1 Sun Pharmaceutical Corporate Summary
7.9.2 Sun Pharmaceutical Business Overview
7.9.3 Sun Pharmaceutical Etoricoxib Intermediate Major Product Offerings
7.9.4 Sun Pharmaceutical Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.9.5 Sun Pharmaceutical Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Etoricoxib Intermediate Major Product Offerings
7.10.4 GlaxoSmithKline Etoricoxib Intermediate Sales and Revenue in Global (2016-2021)
7.10.5 GlaxoSmithKline Key News
8 Global Etoricoxib Intermediate Production Capacity, Analysis
8.1 Global Etoricoxib Intermediate Production Capacity, 2016-2027
8.2 Etoricoxib Intermediate Production Capacity of Key Manufacturers in Global Market
8.3 Global Etoricoxib Intermediate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Etoricoxib Intermediate Supply Chain Analysis
10.1 Etoricoxib Intermediate Industry Value Chain
10.2 Etoricoxib Intermediate Upstream Market
10.3 Etoricoxib Intermediate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Etoricoxib Intermediate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Etoricoxib Intermediate in Global Market
Table 2. Top Etoricoxib Intermediate Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Etoricoxib Intermediate Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Etoricoxib Intermediate Revenue Share by Companies, 2016-2021
Table 5. Global Etoricoxib Intermediate Sales by Companies, (MT), 2016-2021
Table 6. Global Etoricoxib Intermediate Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Etoricoxib Intermediate Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Etoricoxib Intermediate Product Type
Table 9. List of Global Tier 1 Etoricoxib Intermediate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Etoricoxib Intermediate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type